![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 15, 13029-13036, April 12, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of ¶ Pathology, § Internal
Medicine, Low density lipoprotein (LDL) oxidation
and monocyte infiltration of the vessel wall underlie atherogenesis.
These cells express cyclooxygenase-2, but the way oxidized LDL
stimulates cyclooxygenase-2 transcription is unknown. Oxidized LDL,
oxidatively fragmented phospholipids isolated from oxidized LDL, a
synthetic oxidized alkylphospholipid (azPC) that is a potent peroxisome
proliferator activated receptor (PPAR)
Cyclooxygenase-2 Is Induced in Monocytes by Peroxisome
Proliferator Activated Receptor
and Oxidized Alkyl Phospholipids
from Oxidized Low Density Lipoprotein*
§,
§,
§,
§, and
§¶
Human Molecular Biology and Genetics Program,
University of Utah, Salt Lake City, Utah 84112
agonist, or the PPAR
agonist rosiglitazone all induced cyclooxygenase-2 expression and
enhanced prostaglandin E2 (PGE2)
secretion in primary human monocytes. The cyclooxygenase-2 inhibitor
NS398 blocked PPAR
-induced PGE2 secretion. Phospholipase A1 and A2 digestion shows that oxidized
alkylphospholipids, and not oxidized fatty acids, were the relevant
agonists. The upstream PPAR-responsive element (PPRE) of
cyclooxygenase-2 was required for induction of a luciferase reporter by
oxidized phospholipids, azPC, and rosiglitazone, and a (COX-2
PPRE)3-luciferase reporter was responsive to these PPAR
agonists. Circulating human monocytes do not contain PPAR
, but
PPAR
was induced rapidly (<4 h) in monocytes upon ligation of
surface ICAM-3, but not P-selectin glycoprotein-1 even though both
interactions prime cytokine secretion. Cyclooxygenase-2 induction by
oxidized phospholipids only occurred in monocytes containing PPAR
.
Thus PPAR
was induced rapidly in primary monocytes by appropriate
outside-in signaling, sensitizing them to previously undetectable
agonists in oxidized LDL. Cyclooxygenase-2 and PGE2
secretion are induced, not inhibited, by selective PPAR
agonists
that include oxidatively fragmented phospholipids in oxidized LDL.
*
This work was supported by National Institutes of Health
Grants HL44513, HL50153, and HL44525.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: 4130 EIHG, 15 North 2030 East, University of Utah, Salt Lake City, UT
84112-5330. Tel.: 801-585-0716; Fax: 801-585-0701; E-mail:
tom.mcintyre@hmbg.utah.edu.
This article has been cited by other articles:
![]() |
R. A. Oyesanya, Z. P. Lee, J. Wu, J. Chen, Y. Song, A. Mukherjee, P. Dent, T. Kordula, H. Zhou, and X. Fang Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells FASEB J, August 1, 2008; 22(8): 2639 - 2651. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paruchuri, Y. Jiang, C. Feng, S. A. Francis, J. Plutzky, and J. A. Boyce Leukotriene E4 Activates Peroxisome Proliferator-activated Receptor {gamma} and Induces Prostaglandin D2 Generation by Human Mast Cells J. Biol. Chem., June 13, 2008; 283(24): 16477 - 16487. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Taketa, T. Matsumura, M. Yano, N. Ishii, T. Senokuchi, H. Motoshima, Y. Murata, S. Kim-Mitsuyama, T. Kawada, H. Itabe, et al. Oxidized Low Density Lipoprotein Activates Peroxisome Proliferator-activated Receptor-{alpha} (PPAR{alpha}) and PPAR{gamma} through MAPK-dependent COX-2 Expression in Macrophages J. Biol. Chem., April 11, 2008; 283(15): 9852 - 9862. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ptasinska, S. Wang, J. Zhang, R. A. Wesley, and R. L. Danner Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway FASEB J, March 1, 2007; 21(3): 950 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Degner, M. Q. Kemp, G. T. Bowden, and D. F. Romagnolo Conjugated Linoleic Acid Attenuates Cyclooxygenase-2 Transcriptional Activity via an Anti-AP-1 Mechanism in MCF-7 Breast Cancer Cells J. Nutr., February 1, 2006; 136(2): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, M. D. Southall, S. M. Mezsick, C. Johnson, R. C. Murphy, R. L. Konger, and J. B. Travers Epidermal Peroxisome Proliferator-activated Receptor {gamma} as a Target for Ultraviolet B Radiation J. Biol. Chem., January 7, 2005; 280(1): 73 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, A. S. Weyrich, G. A. Zimmerman, and T. M. McIntyre Endothelial Cell Confluence Regulates Cyclooxygenase-2 and Prostaglandin E2 Production That Modulate Motility J. Biol. Chem., December 31, 2004; 279(53): 55905 - 55913. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, Y. Ito, K. Wakai, M. Kawado, S. Hashimoto, H. Toyoshima, M. Kojima, S. Tokudome, N. Hayakawa, Y. Watanabe, et al. Serum Oxidized Low-Density Lipoprotein Levels and Risk of Colorectal Cancer: A Case-Control Study Nested in the Japan Collaborative Cohort Study Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1781 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Grau, M. A. Iniguez, and M. Fresno Inhibition of Activator Protein 1 Activation, Vascular Endothelial Growth Factor, and Cyclooxygenase-2 Expression by 15-Deoxy-{Delta}12,14-Prostaglandin J2 in Colon Carcinoma Cells: Evidence for a Redox-Sensitive Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanism Cancer Res., August 1, 2004; 64(15): 5162 - 5171. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shanmugam, I. T. Gaw Gonzalo, and R. Natarajan Molecular Mechanisms of High Glucose-Induced Cyclooxygenase-2 Expression in Monocytes Diabetes, March 1, 2004; 53(3): 795 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cipollone, B. Rocca, and C. Patrono Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 246 - 255. [Abstract] [Full Text] |
||||
![]() |
M. Nie, L. Pang, H. Inoue, and A. J Knox Transcriptional Regulation of Cyclooxygenase 2 by Bradykinin and Interleukin-1{beta} in Human Airway Smooth Muscle Cells: Involvement of Different Promoter Elements, Transcription Factors, and Histone H4 Acetylation Mol. Cell. Biol., December 15, 2003; 23(24): 9233 - 9244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, H. Inoue, L. C. Flowers, and N. Sidell Control of COX-2 Gene Expression through Peroxisome Proliferator-Activated Receptor {gamma} in Human Cervical Cancer Cells Clin. Cancer Res., October 1, 2003; 9(12): 4627 - 4635. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shanmugam, Y. S. Kim, L. Lanting, and R. Natarajan Regulation of Cyclooxygenase-2 Expression in Monocytes by Ligation of the Receptor for Advanced Glycation End Products J. Biol. Chem., September 12, 2003; 278(37): 34834 - 34844. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. de Assis, A. R. Silva, L. F. C. Caiado, G. K. Marathe, G. A. Zimmerman, S. M. Prescott, T. M. McIntyre, P. T. Bozza, and H. C. de Castro-Faria-Neto Synergism Between Platelet-Activating Factor-Like Phospholipids and Peroxisome Proliferator-Activated Receptor {gamma} Agonists Generated During Low Density Lipoprotein Oxidation That Induces Lipid Body Formation in Leukocytes J. Immunol., August 15, 2003; 171(4): 2090 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pang, M. Nie, L. Corbett, and A. J. Knox Cyclooxygenase-2 Expression by Nonsteroidal Anti-inflammatory Drugs in Human Airway Smooth Muscle Cells: Role of Peroxisome Proliferator-Activated Receptors J. Immunol., January 15, 2003; 170(2): 1043 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. McIntyre, A. V. Pontsler, A. R. Silva, A. St. Hilaire, Y. Xu, J. C. Hinshaw, G. A. Zimmerman, K. Hama, J. Aoki, H. Arai, et al. From the Cover: Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist PNAS, January 7, 2003; 100(1): 131 - 136. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |